MX2022003691A - Espectrometria de masas nativa acoplada a cromatografia de interaccion hidrofobica para analisis de anticuerpos. - Google Patents

Espectrometria de masas nativa acoplada a cromatografia de interaccion hidrofobica para analisis de anticuerpos.

Info

Publication number
MX2022003691A
MX2022003691A MX2022003691A MX2022003691A MX2022003691A MX 2022003691 A MX2022003691 A MX 2022003691A MX 2022003691 A MX2022003691 A MX 2022003691A MX 2022003691 A MX2022003691 A MX 2022003691A MX 2022003691 A MX2022003691 A MX 2022003691A
Authority
MX
Mexico
Prior art keywords
mass spectrometry
hydrophobic interaction
interaction chromatography
proteins
peptides
Prior art date
Application number
MX2022003691A
Other languages
English (en)
Inventor
Shunhai Wang
Yuetian Yan
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=72896082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2022003691(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of MX2022003691A publication Critical patent/MX2022003691A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • B01D15/327—Reversed phase with hydrophobic interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
    • H01J49/00—Particle spectrometers or separator tubes
    • H01J49/0027—Methods for using particle spectrometers
    • H01J49/0036—Step by step routines describing the handling of the data generated during a measurement

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona métodos y sistemas rápidos, sensibles y de alto rendimiento para caracterizar péptidos o proteínas con espectrometría de masas nativa acoplada a cromatografía de interacción hidrofóbica para mejorar el proceso de elaboración de productos biofarmacéuticos, tales como identificar impurezas durante la purificación de anticuerpos, controlar las variantes de modificación postraduccional durante la producción o caracterizar la relación fármaco-anticuerpo de los conjugados de anticuerpo y fármaco. Los perfiles de separación de los péptidos o las proteínas se generan y se comparan para identificar o calificar los péptidos o las proteínas.
MX2022003691A 2019-09-27 2020-09-27 Espectrometria de masas nativa acoplada a cromatografia de interaccion hidrofobica para analisis de anticuerpos. MX2022003691A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962907465P 2019-09-27 2019-09-27
PCT/US2020/052975 WO2021062341A1 (en) 2019-09-27 2020-09-27 Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis

Publications (1)

Publication Number Publication Date
MX2022003691A true MX2022003691A (es) 2022-04-26

Family

ID=72896082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022003691A MX2022003691A (es) 2019-09-27 2020-09-27 Espectrometria de masas nativa acoplada a cromatografia de interaccion hidrofobica para analisis de anticuerpos.

Country Status (12)

Country Link
US (3) US11525833B2 (es)
EP (1) EP4034883A1 (es)
JP (1) JP2022549875A (es)
KR (1) KR20220071222A (es)
CN (1) CN114787630A (es)
AU (1) AU2020353178A1 (es)
BR (1) BR112022005317A2 (es)
CA (1) CA3155664A1 (es)
IL (1) IL291660A (es)
MX (1) MX2022003691A (es)
WO (1) WO2021062341A1 (es)
ZA (1) ZA202203400B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202005234XA (en) 2018-01-29 2020-07-29 Ion Opticks Res Pty Ltd Capillary fitting

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
ES2549077T3 (es) * 2004-04-07 2015-10-22 Genentech, Inc. Espectrometría de masas de conjugados de anticuerpos
WO2017151892A2 (en) 2016-03-02 2017-09-08 Waters Technologies Corporation Identification and quantification of conjugated peptides in antibody drug conjugates by mass spectrometry

Also Published As

Publication number Publication date
CN114787630A (zh) 2022-07-22
JP2022549875A (ja) 2022-11-29
KR20220071222A (ko) 2022-05-31
ZA202203400B (en) 2024-01-31
BR112022005317A2 (pt) 2022-06-14
US11885811B2 (en) 2024-01-30
WO2021062341A1 (en) 2021-04-01
US20210102951A1 (en) 2021-04-08
US11525833B2 (en) 2022-12-13
US20230251266A1 (en) 2023-08-10
AU2020353178A1 (en) 2022-04-14
US20240110924A1 (en) 2024-04-04
IL291660A (en) 2022-05-01
CA3155664A1 (en) 2021-04-01
EP4034883A1 (en) 2022-08-03

Similar Documents

Publication Publication Date Title
Mahan et al. A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis
EP4299803A3 (en) Macromolecule analysis employing nucleic acid encoding
EA201491974A1 (ru) Количественное определение примесей для промышленного тестирования пептидных продуктов
ATE529752T1 (de) Antikörperquantifizierung
NZ714079A (en) Purification process for monoclonal antibodies
MX2020000288A (es) Cromatografia.
WO2017189357A3 (en) Charged surface reversed phase chromatographic materials method for analysis of glycans modified with amphipathic, strongly basic moieties
AU2018274704A1 (en) Assay for plasma cell associated disease
MX2019015887A (es) Proteinas de captura de superficie celular recombinantes.
WO2018183779A8 (en) Multiplex isotype-specific antibody detection
PH12017500489A1 (en) Human-derived anti-dipeptide repeats (dprs) antibody
WO2016004233A3 (en) Srm assays to chemotherapy targets
EA202192850A1 (ru) Идентификация белков клетки-хозяина
MX2018012550A (es) Composiciones y metodos para la deteccion de proteinas de celulas huesped.
CY1125303T1 (el) Meθοδοι γia thn aπολyth πoσotikoπoihσh πολυπεπτιδιων xamhλης aφθονιας me th xphσh φασματομετριας mazaς
EA202191931A1 (ru) Способ характеризации видимых и/или невидимых частиц в биологических препаратах
NZ735303A (en) Method and device for preparing and extracting a biomolecule
SG11201908520TA (en) Method for simultaneous quantification of monoclonal antibodies
MX2017009253A (es) Anticuerpos antiglicoproteina y usos de los mismos.
ZA202203400B (en) Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis
KR20220079910A (ko) 숙주-세포 단백질을 특성화하는 방법
BR112016000231A8 (pt) métodos para identificações de condições de separação com cromatografia de troca de íons e para análises de composições de polipeptídeos
AU2021313128A8 (en) Methods for middle down antibody characterization
EP4300101A3 (en) Antigenic peptides and uses thereof for diagnosing and treating autism
MX2022000836A (es) Espectrometria de masas natural conectada a cromatografía por afinidad para análisis de anticuerpos.